ACR16 10 mg ( DrugBank: ACR-16 )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

8. ハンチントン病

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00724048 (ClinicalTrials.gov)	October 2008	24/7/2008	A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease	A Multi-center, North American, Randomized, Double-blind, Parallel Group Study Comparing Three Doses ...	Huntington Disease	Drug: ACR16 10 mg;Drug: ACR16 22.5 mg;Drug: ACR16 45 mg;Other: Placebo	Teva Pharmaceutical Industries	NULL	Completed	30 Years	N/A	Both	227	Phase 2/Phase 3	United States;Canada

First Previous1Next Last